FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention relates to compound of formula (I), its pharmaceutically acceptable salt or solvate, in which R1 represents lower alkyl, Y represents -S(O)n-, where n equals 1 or 2, R2 represents hydrogen or lower alkyl, R1 and R2 together can form lower alkylene, R7 represents hydrogen, X represents group of formula: [formula 2], where R3, R4, R5 and R6 each independently represent hydrogen, group of formula: [formula 3] represents C5-C6-cvycloalkylene, p and q each independently equals integer number from 0 to 2, p or q is not equal 0, and Z represents optionally substituted phenyl, optionally substituted pyridyl, optionally substituted pyridasinyl, optionally substituted pyrasolyl, optionally substituted indanyl, optionally substituted benzothiazolyl, optionally substituted benzoxazolyl, optionally substituted thiazolopyridyl, optionally substituted oxazolopyridyl, optionally substituted benzimidasolyl, optionally substituted benzoxazinonyl, optionally substituted chinolyl, optionally substituted isochinolyl, optionally substituted benzoxazolinonyl, optionally substituted benzoxazolinonyl or optionally substituted ftalazinyl.
EFFECT: obtaining pharmaceutical composition, obtaining antagonistic activity with respect to receptor NPY Y5, based on said compounds.
14 cl, 1 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
PYRIDYLALKENE AND PYRIDYLALKYNE ACID AMIDES, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF ITS PREPARING | 1997 |
|
RU2200734C2 |
SULFONAMIDE COMPOUND | 1998 |
|
RU2199532C2 |
DERIVATIVES OF HYDROXYIMINOALKANOIC ACID, PHARMACEUTICAL COMPOSITION AND AGENT FOR REGULATION OF RETINOID RECEPTORS | 1999 |
|
RU2213738C2 |
2,6,9-TRISUBSTITUTED PURINE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE CATIONIC SALT, METHOD FOR INHIBITION OF CELL PROLIFERATION, PHARMACEUTICAL COMPOSITION | 1997 |
|
RU2220968C2 |
6,7-UNSATURATED 7-CARBAMOYL SUBSTITUTED MORPHINANDERIVATIVE | 2006 |
|
RU2403255C2 |
DERIVATIVES SHOWING PPAR-RECEPTOR AGONIST ACTIVITY | 2006 |
|
RU2415846C2 |
BENZODIAZEPINE COMPOUND AND PHARMACEUTICAL COMPOSITION | 2009 |
|
RU2496775C2 |
METHOD FOR SYNTHESIS OF SULPHAMATE-CARBOXYLATE DERIVATIVES | 2006 |
|
RU2403238C2 |
MONOMER DERIVATIVES OF GLYCOPEPTIDE ANTIBIOTIC | 2005 |
|
RU2424248C2 |
AMINOTHIAZOLE INHIBITORS OF CYCLIN-DEPENDENT KINASES | 1998 |
|
RU2211839C2 |
Authors
Dates
2011-11-10—Published
2007-04-25—Filed